Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
NCT07688928
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Primary Aldosteronism
Endocrine Hypertension
Interventions
DRUG:
Finerenone
Sponsor
Bangladesh Medical University